(Q46516117)

22 December 2017

title

Stability and validity of memory-based subtypes of schizophrenia (English)

1 reference

22 December 2017

1 reference

Stephanie McDermid Vaz

series ordinal

1

1 reference

22 December 2017

R Walter Heinrichs

series ordinal

2

1 reference

22 December 2017

publication date

1 November 2006

1 reference

22 December 2017

Journal of the International Neuropsychological Society

published in

1 reference

22 December 2017

volume

12

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

782-791

1 reference

22 December 2017

Five latent factors underlying schizophrenia: analysis and relationship to illnesses in relatives.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Schizophrenia and memory impairment: evidence for a neurocognitive subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Neuropsychological impairments in neuroleptic-responder vs. -nonresponder schizophrenic patients and healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Parsing schizophrenia with neurocognitive tests: evidence of stability and validity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Neurocognitive subtypes of chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

The primacy of cognition in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Meta-analysis and the science of schizophrenia: variant evidence or evidence of variants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Neuropsychological correlates of positive vs. negative schizophrenic symptomatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

What are the functional consequences of neurocognitive deficits in schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Distinguishing separable domains of cognition in human and animal studies: what separations are optimal for targeting interventions? A summary of recommendations from breakout group 2 at the measurement and treatment research to improve cognition in

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Does cognitive function improve with quetiapine in comparison to haloperidol?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

The endophenotype concept in psychiatry: etymology and strategic intentions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Memory-delineated subtypes of schizophrenia: relationship to clinical, neuroanatomical, and neurophysiological measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Selectivity of verbal memory deficit in schizophrenic patients and their relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

Demographically corrected norms for the California Verbal Learning Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

7 January 2021

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

7 January 2021

Symptom monitoring in the rehabilitation of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

7 January 2021

Neuropsychological profiles delineate distinct profiles of schizophrenia, an interaction between memory and executive function, and uneven distribution of clinical subtypes

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

7 January 2021

Premorbid and onset features of first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

7 January 2021

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

7 January 2021

The nature of learning and memory impairments in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

7 January 2021

Neuropsychological differences between young and old schizophrenics with and without associated neurological dysfunction

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

7 January 2021

Neuropsychological heterogeneity in schizophrenia: a consideration of abstraction and problem-solving abilities

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

7 January 2021

Release from proactive inhibition in schizophrenia and its potential as a genotypic marker

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

7 January 2021

Bootstraps taxometrics. Solving the classification problem in psychopathology

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

7 January 2021

Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617706060966

7 January 2021

10.1017/S1355617706060966

Identifiers

DOI

0 references

1 reference

22 December 2017